staar surgical co stock

6 months ago - Benzinga. STAAR Surgical STAA 117 stock rose following its earnings results where Q4 net sales grew 28 YY to 59M.

Staar Surgical Company Jobs Comparably

Engages in the development manufacture production marketing and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye.

. Wall Street analysts predict earnings per share of 0170. The company said the increase was driven by ICL sales and unit growth of 33 and 36. This suggests a possible upside of 1381 from the stocks current price.

No significant news for in the past two years. This compares to earnings of 014 per share a year ago. Latest Stock Picks.

News Staar Surgical Co. STAAR Surgical Company presents Q4 figures on February 23. STAAR designs develops manufactures and markets implantable lenses for the eye with companion delivery systems.

Staar Surgical STAA Loses 142 in 4 Weeks Heres Why a Trend Reversal May be Around the Corner Zacks - Fri Jan 14 900AM CST Staar Surgical STAA has become technically an oversold stock now which implies exhaustion of the heavy selling pressure on it. Their forecasts range from 15000 to 15000. Real time STAAR Surgical STAA stock price quote stock graph news analysis.

STAA shares down more than 50 in the past six months stockholders are in sore need of some good news. View the STAA premarket stock price ahead of the market session or assess the after hours quote. Dive deeper with interactive charts and top stories of STAAR SURGICAL COMPANY.

STAA Staar Surgical Co - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. A high-level overview of STAAR Surgical Company STAA stock. The growth was attributable to global ICL sal.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. STAAR Surgical Company stock price live 7674 this page displays NASDAQ STAA stock exchange data. These lenses are intended to provide visual freedom for patients lessening or eliminating the reliance on glasses or contact lenses.

Get STAAR Surgical Co STAANASDAQ real-time stock quotes news price and financial information from CNBC. Uplifts FY21 Outlook STAAR Surgical Company NASDAQ. This combined with strong agreement among Wall Street analysts in revising.

1 brokers have issued 12 month price targets for STAAR Surgicals stock. BNK Invest Oct 13 2021 With STAAR Surgical Companys NASDAQSTAA price down 60 this week insiders might find some solace having sold US97m worth of. Ticking those two boxes is a good sign of growth in my book.

1 day agoIn other STAAR Surgical news CTO Keith Holliday sold 6000 shares of STAAR Surgical stock in a transaction dated Tuesday December 14th. With STAAR Surgical NASDAQ. The Companys principal products are implantable Collamer lenses ICLs and intraocular lenses IOLs.

View the latest STAA stock quote and chart on MSN Money. STAAR Surgical Stock Surges 21 After Q2 Sales Beat Expectations. STAAR Surgical Company is a developer producer and marketer of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye.

Who is STAAR Surgical. STAAR Surgical Company is followed by the analysts listed above. ICLs consists of the Companyâs ICL family of products including the Toric.

Please note that any opinions estimates or forecasts regarding STAAR Surgical Companys performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of STAAR Surgical Company or its management. Staar Surgical STAA came out with quarterly earnings of 019 per share beating the Zacks Consensus Estimate of 016 per share. Key Stock Data PE Ratio TTM 16367 021122 EPS TTM 046 Market Cap.

As of February 25 2022 STAAR Surgical Company had a 36 billion market capitalization compared to the Medical Equipment Supplies Distribution median of 5590 million STAAR Surgical Companys stock is down 159 in 2022 up 115 in the previous five trading days and down 262 in the past year. Watch STAAR Surgical Company stock price move in real-time ahead here. All of these lenses are foldable which permits the surgeon to insert.

The stock was sold at an average price of 8957 for a. STAAR Surgical shareholders can take confidence from the fact that EBIT margins are up from 39 to 14 and revenue is growing. On average they expect STAAR Surgicals stock price to reach 15000 in the next twelve months.

STAA Q2 sales increased 77 YY to 624 million and up 23 on a sequential basis beating the consensus of 5256 million. STAAR Surgical Company STAA Q3 2021.

Staar Surgical Co Advanced Charts Staa Barron S